Evidence map›Paper›PMID 35015250›Full record

ArticleMolecular neurobiology2022

piRNA/PIWI Protein Complex as a Potential Biomarker in Sporadic Amyotrophic Lateral Sclerosis.

Rehab F Abdelhamid, Kotaro Ogawa, Goichi Beck, Kensuke Ikenaka, Eriko Takeuchi, Yoshiaki Yasumizu, Jyunki Jinno, Yasuyoshi Kimura, Kousuke Baba, Yoshitaka Nagai and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. piENOX2 regulates ALKBH5-mediated Itga4 mExperimental & molecular medicine · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. CODA: a combo-Seq data analysis workflow.Briefings in bioinformatics · 2023
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Rehab F AbdelhamidDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kotaro OgawaDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Goichi BeckDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kensuke IkenakaDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Eriko TakeuchiDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yoshiaki YasumizuDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Jyunki JinnoDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yasuyoshi KimuraDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kousuke BabaDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yoshitaka NagaiDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yukinori OkadaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yuko SaitoDepartment of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.
Shigeo MurayamaDepartment of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi, Tokyo, Japan.
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Seiichi NaganoDepartment of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. nagano@neurol.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0002-0826-177X
The University of Osaka · JPTokyo Metropolitan Geriatric Hospital · JPKindai University · JP

Funding

Grant-in-Aid for Scientific Research on Innovative Areas 16H06277Grants-in-Aid for Scientific Research (C) 16K09690Grants-in-Aid for Scientific Research (C) 22590932Grants-in-Aid for Scientific Research (C) 25461302Japan Agency for Medical Research and Development JP18dm0107103Japan Agency for Medical Research and Development JP20ek0109320Japan Agency for Medical Research and Development JP20lm0203007
6 · The paper itself

Abstract

The pathological hallmark of the majority of amyotrophic lateral sclerosis (ALS) cases is the mislocalization and aggregation of TAR DNA-binding protein 43 (TDP-43), an RNA-binding protein. Several studies have attributed disease processes of ALS to abnormal RNA metabolism. However, dysregulated biogenesis of RNA, especially non-coding RNA (ncRNA), is poorly understood. To resolve it, RNA-Seq, biochemical, and immunohistochemical analyses were performed on the pyramidal tract of the medulla oblongata of sporadic ALS (sALS) and control postmortem brain samples. Here, we report perturbation of ncRNA biogenesis in PIWI-interacting RNA (piRNA) in several sALS brain samples associated with TDP-43 pathology. In addition, we confirmed the dysregulation of two PIWI homologs, PIWI-like-mediated gene silencing 1 (PIWIL1) and PIWIL4, which bind to piRNAs to regulate their expression. PIWIL1 was mislocalized and co-localized with TDP-43 in motor neurons of sporadic ALS lumbar cords. Our results imply that dysregulation of piRNA, PIWIL1, and PIWIL4 is linked to pathogenesis of ALS. Based on these results, piRNAs and PIWI proteins are potential diagnostic biomarkers and therapeutic targets of ALS.

Indexed as

Amyotrophic Lateral SclerosisArgonaute ProteinsBiomarkersHumansMotor NeuronsRNA, Small InterferingArgonaute ProteinsBiomarkersPIWIL1 protein, humanRNA, Small InterferingAmyotrophic lateral sclerosismiRNApiRNAPIWI proteinTDP-43

Identifiers

PMID35015250
PMCPMC8882100
OpenAlexW4206384023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.